Your browser doesn't support javascript.
loading
Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience.
Richard-Carpentier, Guillaume; Kantarjian, Hagop M; Tang, Guilin; Yin, C Cameron; Khoury, Joseph D; Issa, Ghayas C; Haddad, Fadi; Jain, Nitin; Ravandi, Farhad; Short, Nicholas J; DiNardo, Courtney D; Takahashi, Koichi; Konopleva, Marina Y; Daver, Naval G; Kadia, Tapan; Garcia-Manero, Guillermo; Garris, Rebecca; O'Brien, Susan; Jabbour, Elias.
Afiliação
  • Richard-Carpentier G; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX.
  • Kantarjian HM; Division of Hematology, Department of Medicine, Queen's University, Kingston, ON, Canada.
  • Tang G; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX.
  • Yin CC; Division of Pathology and Laboratory Medicine, Department of Hematopathology, University of Texas, MD Anderson Cancer Center, Houston, TX; and.
  • Khoury JD; Division of Pathology and Laboratory Medicine, Department of Hematopathology, University of Texas, MD Anderson Cancer Center, Houston, TX; and.
  • Issa GC; Division of Pathology and Laboratory Medicine, Department of Hematopathology, University of Texas, MD Anderson Cancer Center, Houston, TX; and.
  • Haddad F; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX.
  • Jain N; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX.
  • Ravandi F; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX.
  • Short NJ; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX.
  • DiNardo CD; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX.
  • Takahashi K; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX.
  • Konopleva MY; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX.
  • Daver NG; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX.
  • Kadia T; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX.
  • Garcia-Manero G; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX.
  • Garris R; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX.
  • O'Brien S; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX.
  • Jabbour E; Division of Hematology/Oncology, Department of Medicine, UCI Health, Orange, CA.
Blood Adv ; 5(23): 5415-5419, 2021 12 14.
Article em En | MEDLINE | ID: mdl-34525185
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos